Mediclinic International
MDC: 743.50 6.25 (▲0.85%)
| Bid Price | 742.50 | High Price | 744.50 |
|---|---|---|---|
| Ask Price | 744.00 | Low Price | 734.00 |
| Open Price | 734.00 | Spread | 0.20% |
| Prev Close | 737.00 | Volume | 140,968.00 |
Mediclinic International Share Price Chart
Intraday
Historic – 1 year
Mediclinic International Share Price Information
| Name | Mediclinic International | Epic | MDC |
|---|---|---|---|
| Sector | Health Care Equipment & Services | ISIN | GB00B8HX8Z88 |
| Activites | Al Noor Hospitals Group is the largest integrated private healthcare service provider in the Emirate of Abu Dhabi based on the number of patients treated, number of beds and number of physicians as stated in the Health Authority of Abu Dhabi’s (HAAD) latest report. The Company provides primary, secondary and tertiary care through three hospitals and nine medical centres. The provision of care is at international standards, with a particular focus on clinical excellence and patient safety. Al Noor was the first private hospital in Abu Dhabi City to obtain Joint Commission International (JCI) accreditation, and today all of its hospitals are accredited. Al Noor operates in one of the fastest growing industries in the UAE due to: population growth and a rapidly ageing demographic; an increasing incidence of lifestyle-related medical conditions such as diabetes and obesity; service gaps in the current healthcare market; and growth in the privately insured population in the UAE. | Security Type | Equity |
Key numbers
| Latest Share Price (p) | 743.25 | Net Gearing (%) | 40.83 |
|---|---|---|---|
| Market Cap (£m) | 5,193.88 | Gross Gearing (%) | 45.49 |
| Shares in issue (m) | 737.24 | Debt Ratio | 38.04 |
| P/E Ratio | 23.80 | Debt-to-Equity Ratio | 0.74 |
| Divs per share (p) | 7.00 | Assets / Equity Ratio | 1.83 |
| Dividend Yield (%) | 0.00 | Price to book value | 1.45 |
| Dividend Cover | 0.00 | SROCE (%) | 4.25 |
| Earning per share (p) | 29.60 | EPS Growth (%) | |
| 52-week high / low (p) | 1,174.00 / 675.50 | DPS Growth (%) | -44.88 |
Mediclinic International Broker Views
| Date | Broker | Rec. | Price | Old target price | New target price | Notes |
|---|---|---|---|---|---|---|
| 29 Nov | Jefferies International | Hold | 743.50 | 812.00 | 741.00 | Reiterates |
| 23 Nov | Macquarie | Neutral | 743.50 | 970.00 | 830.00 | Reiterates |
| 11 Nov | HSBC | Reduce | 743.50 | 920.00 | 745.00 | Reiterates |
| 28 Sep | Jefferies International | Hold | 743.50 | 833.00 | 812.00 | Reiterates |
| 22 Sep | Jefferies International | Hold | 743.50 | 920.00 | 833.00 | Reiterates |
Mediclinic International Director Deals
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 29 Nov 2016 | Alan Grieve | Buy | 7500 @ 734.30p | £55,072.50 |
Mediclinic International Company News
Broker Forecast – Jefferies International issues a broker note on Mediclinic International Plc
Jefferies International today reaffirms its hold investment rating on Mediclinic International Plc (LON:MDC) and cut its price target to 741p (from 812p).
Story provided by StockMarketWire.com
Director Deals – Mediclinic International Plc (MDC)
Alan Grieve, Non Executive Director, bought 7,500 shares in the company on the 28th November 2016 at a price of 734.30p. The Director now holds 7,500 shares representing 0.00% of the shares in issue.
NOTE: Average price
Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com
Broker Forecast – Macquarie issues a broker note on Mediclinic International Plc
Macquarie today reaffirms its neutral investment rating on Mediclinic International Plc (LON:MDC) and cut its price target to 830p (from 970p).
Story provided by StockMarketWire.com
Broker Forecast – HSBC issues a broker note on Mediclinic International Plc
HSBC today reaffirms its reduce investment rating on Mediclinic International Plc (LON:MDC) and cut its price target to 745p (from 920p).
Story provided by StockMarketWire.com
FTSE falls on stronger pound
The FTSE 100 closed 1% down as National Grid (NG.) and British American Tobacco (BATS) pulled the blue chip index lower.
Sterling strengthened against the dollar by 0.2% to $1.24, a potential headwind for blue chip overseas earners.
US initial unemployment claims fell by 11,000 in the week to 5 November from the previous week’s unrevised level of 265,000.
West Texas Intermediate (WTI) crude oil was 1% lower at $44.82 and Brent crude oil fell 0.7% to $46 per barrel, respectively.
Gold fell 0.6% to $1,264 per ounce.
FTSE 100 RISERS AND FALLERS
Cyclical industrial stocks including equipment hire outfit Ashtead (AHT) and builders merchant Travis Perkins (TPK) continued to rally following Trump’s win.
Fresnillo (FRES) and Randgold Resources (RRS) gave back some of the near-double digit gains achieved in the wake of Trump’s election win.
Copper miner Antofagasta (ANTO) was one of the biggest risers on the stock market as copper continued its rally. The metal gained 3% to $5,577 per tonne.
Barclays (BARC) traded 4.2% higher at 201p, as financial stocks gained on the prospects of higher interest rates and better interest rate margins.
Shares in Mediclinic (MDC) slumped after it reported that revenue growth in the Middle East is expected at the bottom end of expectations. This was blamed on the continued weak macro-economic environment and the delayed opening of its Al Jowhara facility.
National Grid disappointed investors as pre-tax profit fell from £1,371m in the six months to 30 September 2015 to £1,359m over the same period this year.
Private equity firm 3i (III) dipped 7.8% to 604.5p despite its NAV increasing from 463p on 31 March 2016 to 551p on 31 September.
FTSE 250 RISERS AND FALLERS
Construction trade supplier Grafton (GFTU) was on higher ground despite like-for-like revenue growth slowing to 2.4% in the four months to 31 October, compared to 4.2% growth in the preceding six months.
Superdry brand owner SuperGroup (SGP) advanced on a better-than-expected first half trading and strategy update. The firm shrugged off warm weather in August and September to deliver 12.8% growth in like-for-like sales, with wholesale revenues up nearly 44%.
Bicycles retailer Halfords (HFD) reversed 4.7% to 327.3p as interim results revealed a sharp drop in earnings, with margins impacted by the weaker pound, cycling product promotions and investments in long-term growth.
SMALL CAP RISERS AND FALLERS
ServicePower Technologies (SVR) soared 60% to 4p on confirmation that it is in preliminary discussions with Jonas Computing, which could lead to a takeover offer.
A profit warning caused sausage skins maker Devro (DVO) to crash 17.4% to 186.5p. Amid muted sales in Latin America, Devro will invest in new products and manufacturing efficiencies to improve its competitive position.
Wincanton (WIN) surged 8.4% to 202p as chief executive Adrian Colman flags falling net debt and rising profitability as an opportunity to invest further in growing the business.
Juicier profit margins helped the logistics specialist to a 19.2% gain in underlying operating profit, at £26.1m. Revenue declined slightly as Wincanton exits loss-making contracts.
Mobile Streams (MOS) plummeted 27.8% to 10p after slumping from a profit of £0.83m to a loss before tax of £0.74m.
Wireless solutions developer Starcom (STAR) climbed 7.5% after Amerijet Airlines approved its Kylos Air GPS tracking device for Air Cargo.
Ophir’s (OPHR) subsidiary Ophir Holdings & Ventures signed a binding shareholders’ agreement to establish a joint operating company to develop the Fortuna project.
Story provided by StockMarketWire.com
